Pharmafile Logo

payer survey

- PMLiVE

AstraZeneca announces promising late-stage results for Imfinzi in gastric cancer

Almost one million cases of the disease are diagnosed globally every year

- PMLiVE

Takeda/Protagonist share positive phase 3 results for rusfertide in rare blood cancer

Up to 160,000 people in the US are affected by polycythaemia vera

- PMLiVE

What is it all for?

The role of healthcare comms in the fight to help improve health and wellness

- PMLiVE

REGISTER NOW – Not Just a Number: Making Sure Every Voice Shapes the Future of Medicine

Health Equity: Why Lived Experience Matters Medicine is constantly evolving, but progress is only meaningful if it reaches everyone. Health outcomes are shaped not just by science, but by social...

Origins – The Patient Focused Specialists

Fostering Fun and Engagement – Building Company Culture Virtually

Who says remote work can't be fun? Discover creative ways to boost morale and keep your life sciences team engaged with virtual activities!

Impetus Digital

- PMLiVE

solli – The Evolving Global Media Landscape for Healthcare Professionals

Red hot preview coming to you today, as we’re soon to launch our new Media Vitals Global HCP report, offering insights around HCPs’ media needs around the globe. Solli dove...

CMI Media Group

- PMLiVE

CMI Media Group unveils inaugural Media Vitals HCP Global research

Healthcare agency CMI Media Group, a WPP company (NYSE: WPP), has unveiled its first ever Media Vitals(TM) HCP Global research. The new report provides insights into the media preferences of...

CMI Media Group

- PMLiVE

solli – Personalization in HCP Media

One-size-fits-all doesn’t fit – in today’s global marketplace, personalization is the best way to engage key audiences. In this new solli article by Matt Durham, VP, Global Engagement Strategy, Matt...

CMI Media Group

- PMLiVE

solli – Pharma Media and the Imperative of Health Equity

Insights from CMI’s Media Vitals 2025 Focus on Health Equity.

CMI Media Group

- PMLiVE

Novo Nordisk and Gensaic enter cardiometabolic disease partnership worth $354m

The companies will use Gensaic’s protein design technology to discover protein ligands

- PMLiVE

Eli Lilly’s Jaypirca recommended by CHMP to treat chronic lymphocytic leukaemia

Approximately 100,000 new cases of the disease are diagnosed globally every year

regeneron headquarters

Regeneron receives positive CHMP opinion for linvoseltamab in multiple myeloma

More than 35,000 new cases of the blood cancer are diagnosed every year in Europe

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links